DTech
DTechCon is a private annual conference operator running the World Congress of Diabetes Technology & Therapeutics, serving endocrinologists, researchers, startups, and corporate sponsors with a capacity-limited, multi-track international congress plus on-demand session recordings.
- Company typePrivate
- Founded-
- HeadquartersAhmedabad, India
- Headcount1–10
- GTM typeB2B
- OfferingServices
What DTech does
DTechCon (legally operated as "DTechCon | World Congress of Diabetes Technology & Therapeutics" and managed through Rx Events Consultancy, Ahmedabad) is a private annual conference business that curates a high-end, capacity-limited international congress focused on diabetes technology and therapeutics. It serves endocrinologists, diabetologists, researchers, T1D advocates, health-tech startups, and corporate sponsors with a curated agenda spanning continuous glucose monitoring (CGM), automated insulin delivery (AID), obesity management, artificial pancreas systems, stem cell and gene therapy in diabetes, and emerging AI applications in clinical practice. The offering comprises the core three-day conference plus specialized paid tracks (CGM Academy, AID Masterclass, Obesity Master Class, Practical AI Workshop), an abstract submission and peer-review pipeline for researchers, a complimentary Startup Pavilion for pre-revenue diabetes tech companies, a tiered sponsorship program for industry partners, and on-demand archived session recordings spanning 2022-2026.
The underlying "technology" is a content and community platform rather than a software product: there are no proprietary algorithms, no published AI/ML models, no APIs, and no mobile app; distribution is built around the dtechcon.com website, the rxregistrations.com registration portal, and direct sponsorship sales outreach. Marketing runs through social (Facebook, X, Instagram, LinkedIn) and email ([email protected]). The business is organized by a small operational team (approximately 9 employees) supporting an organizing committee of senior diabetologists including the Org. Chairman, Scientific Chair/Co-Chair, President, Secretary, and Treasurer, with patrons drawn from prominent India-based endocrinology figures.
Revenue is generated from two streams: (1) delegate registrations across multiple categories with tiered cancellation refund terms (50% before 24-Feb-2025; 30% before 15-Apr-2025; non-refundable thereafter), and (2) corporate sponsorship packages sold to diabetes technology device and therapeutics companies seeking access to the delegate audience. The model is event-driven and annually recurring, with the 2027 edition scheduled for 1-2 May 2027 in Goa, India following the 8-10 May 2026 in-person edition and a prior virtual inaugural that drew 4,000+ delegates globally.
DTech firmographics
Firmographics- Name
- DTech
- Legal name
- DTechCon | World Congress of Diabetes Technology & Therapeutics
- Website
- https://dtechcon.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- DTechCon is a private annual conference operator running the World Congress of Diabetes Technology & Therapeutics, serving endocrinologists, researchers, startups, and corporate sponsors with a capacity-limited, multi-track international congress plus on-demand session recordings.
- Ownership category
- akta.pro rank
DTech industry classification
Industry- Product category
- Medical Conferences
- NAICS
- Convention and Trade Show Organizers (561920)
- akta.pro primary industry
- Virtual/Hybrid Conference Production & Platform Management (THAHACAM)
- akta.pro secondary industry
- Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)
Keywords
Where DTech is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
DTech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Others
Revenue model
- Conference Registrations: Revenue generated from delegate registrations for the annual World Congress event. The conference offers exclusive, limited-capacity attendance with multiple registration categories and cancellation refund policies.
- Sponsorship Packages: Corporate sponsors pay to showcase their brands to a highly engaged audience of healthcare professionals, researchers, innovators, and industry leaders at the conference.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | One time/ perpetual license | Conference Registration with Refund Options |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
DTech product offering
Product offeringCore offering
DTech organizes and runs DTechCon, the annual World Congress of Diabetes Technology & Therapeutics held in Goa, India. The conference delivers multi-track scientific sessions, hands-on workshops, abstract presentations, and a Startup Pavilion for healthcare professionals, researchers, and industry partners focused on diabetes technology. Operations are delivered in partnership with Rx Events Consultancy and supported by online registration, abstract submission, and recordings platforms.
Product overview
DTechCon (World Congress of Diabetes Technology & Therapeutics) is a conference organization that produces annual international events focused on diabetes technology and therapeutics. The core offering is the DTechCon conference, supplemented by specialized educational tracks including CGM Academy, AID Masterclass, Obesity Master Class, and Practical AI Workshop. Additional services include abstract submission for research presentations, sponsorship packages, and archived conference recordings. The organization also supports innovation through a Startup Pavilion for early-stage companies. No unified software product platform exists; the offerings are event-based educational and networking services.
Differentiator
Problem solved
Functional benefit
Products and services
- DTechCon (World Congress of Diabetes Technology & Therapeutics) Multi-day annual congress for endocrinologists, diabetologists, researchers, and industry partners, featuring keynote sessions, scientific abstract presentations, hands-on workshops, and a Startup Pavilion. Designed for senior clinicians seeking updates on diabetes technology evidence and practice.
- Corporate Sponsorship Packages Tiered sponsorship and exhibition packages offered to medical device, pharmaceutical, and digital health companies seeking visibility and lead generation among the congress's clinical audience. Includes Startup Pavilion slots for emerging diabetes-tech ventures.
- Abstract Submission Service Online platform enabling clinical and academic researchers to submit original abstracts for consideration as oral or poster presentations at DTechCon, with international faculty review.
- DTechCon Recordings Archive On-demand video archive of past DTechCon sessions, made available for continued learning and reference by delegates and the broader diabetes clinical community.
Quantifiable outcome
- Over 4,000 delegates attended inaugural virtual event
- +1 more outcomes
Companies that use DTech
Customer profileSegments5 records
Ideal customer profiles3 records
DTech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
DTech partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
DTech competitors and assessment
Company assessmentDirect peers
- JDRF (Breakthrough T1D) International Conferences: JDRF/Breakthrough T1D convenes international summits and research conferences focused on Type 1 diabetes technology, cure research, and advocacy — directly overlapping with DTechCon's T1D advocate segment and technology-focused content streams.
- Advanced Technologies & Treatments for Diabetes (ATTD): ATTD is the leading international congress focused specifically on diabetes technologies and treatments, directly overlapping with DTechCon's positioning around CGMs, insulin pumps, AID systems, and AI in diabetes care. It is the closest functional peer in terms of audience, content scope, and sponsor mix.
- ISPAD Annual Conference: The International Society for Pediatric and Adolescent Diabetes (ISPAD) holds an annual conference addressing pediatric and adolescent diabetes including technology use in T1D, overlapping directly with DTechCon's Type 1 Diabetes track and CGM/AID-focused content.
Others
- ENDO (Endocrine Society Annual Meeting):
- Rx Events Consultancy: Rx Events Consultancy is the outsourced Professional Conference Organizer that physically executes DTechCon and runs other healthcare congresses in India. It is an operational/ecosystem partner rather than a competitor, but its role as a multi-conference PCO gives it directly comparable capabilities in the same market.
Broad incumbents
- ADA Scientific Sessions: The American Diabetes Association's flagship annual meeting is the dominant global diabetes congress, drawing tens of thousands of clinicians and researchers with deep sponsor support from pharma and device companies. DTechCon competes with ADA for KOL mindshare and sponsor dollars, particularly in the diabetes-technology subtrack.
- AACE Annual Scientific & Clinical Congress: The American Association of Clinical Endocrinology's annual congress brings together endocrinologists and includes substantial diabetes-technology programming. It competes with DTechCon for clinical endocrinology KOL participation and medical-device sponsorships.
- EASD Annual Meeting: The European Association for the Study of Diabetes annual meeting is one of the largest endocrinology/diabetes congresses worldwide and competes for international faculty and European sponsors. It overlaps with DTechCon's diabetes technology content.
Regional players
- Research Society for the Study of Diabetes in India (RSSDI): RSSDI is the primary Indian diabetes research society hosting the country's largest annual diabetology congress. It is a regional peer with strong overlap in target audience (Indian diabetologists/endocrinologists) and competes for Indian faculty time and sponsorships.
- Diabetes UK Professional Conference: Diabetes UK's annual professional conference is the largest UK diabetes congress for clinicians and researchers. It is a regional peer with similar format (single-track, expert faculty, sponsor showcases) and overlapping diabetes-technology content.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
DTech social profiles
Digital presenceDTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
DTech leadership team
Management profileNumber of profiles
Profiles10 records
DTech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DTech
What does DTech do?
DTech organizes and runs DTechCon, the annual World Congress of Diabetes Technology & Therapeutics held in Goa, India. The conference delivers multi-track scientific sessions, hands-on workshops, abstract presentations, and a Startup Pavilion for healthcare professionals, researchers, and industry partners focused on diabetes technology. Operations are delivered in partnership with Rx Events Consultancy and supported by online registration, abstract submission, and recordings platforms.
Is DTech a public or private company?
DTech is a private company. It is classified as unknown and is currently operating.
When was DTech founded?
DTech was founded in -1. It employs 1 to 10 people.
Where is DTech based?
DTech is headquartered in Ahmedabad, India, in the Asia region.
How does DTech make money?
Two revenue lines are on record. Conference Registrations are the primary driver. The others are sponsorship Packages.
Who are DTech's main competitors?
Direct peers on record are JDRF (Breakthrough T1D) International Conferences, Advanced Technologies & Treatments for Diabetes (ATTD) and ISPAD Annual Conference. Others are ENDO (Endocrine Society Annual Meeting) and Rx Events Consultancy. Broad incumbents are ADA Scientific Sessions, AACE Annual Scientific & Clinical Congress and EASD Annual Meeting. Regional players are Research Society for the Study of Diabetes in India (RSSDI) and Diabetes UK Professional Conference.
Does DTech have an API?
No public API is recorded for DTech.
What industry is DTech in?
DTech's product category is Medical Conferences. Its primary akta.pro industry code is THAHACAM, Virtual/Hybrid Conference Production & Platform Management, with a secondary code of HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators). Its NAICS code is 561920.